Kisspeptin Studied in Trial on Body Composition, Hormones, Exercise

A clinical trial involving kisspeptin was listed as recruiting on October 15, 2026. The study, registered as NCT06970457, is titled "The Interaction of Body Composition, Sex Hormones and Exercise in Men." The trial's phase is listed as not applicable. Its current status is recruiting, according to the trial record. Kisspeptin remains classified as an unapproved compound used only in research settings. This update reflects the recruitment status as recorded on the specified date, with no results reported at this stage. The trial record does not describe specific outcomes, dosing protocols, or conclusions. No efficacy or safety findings have been disclosed as part of this update. Readers should note that recruiting status indicates the study is actively enrolling participants, not that findings have been generated. Further developments regarding phase progression or results will depend on future updates to the trial registry. For additional context on kisspeptin, including its research background and regulatory status, readers can consult the compound overview.